Pharmaceuticals
Breast Cancer: Hormone Therapy Has a Bigger Impact Than Chemotherapy on Women's Quality of Life - Research by Institut Gustave Roussy
PARIS, Oct. 9, 2019 /PRNewswire/ -- Analysis of the CANTO cohort published in
the journalAnnals of Oncology
2019-10-09 07:00
1826
Chipscreen and Novogene enter a strategic partnership for companion diagnostics development
SHENZHEN, China, Oct. 8, 2019 /PRNewswire/ -- Chipscreen Biosciences Co., Ltd. (Chipscreen, Stock Symbol: 688321.SH) and Novogene Co., Ltd. (Novogene) recently announced a strategic partnership for companion diagnostics (CDx) development. Under the agreement, Novogene will develop a CDx for Chips...
2019-10-08 20:46
3909
Drugstore Chain Mik Japan Launches International "Samurai Drugstore" Online Store with USD 100,000 Point-Back Campaign
OSAKA, Japan, Oct. 8, 2019 /PRNewswire/ -- Established 48 years ago in Japan, Mik Japan Co., Ltd. (Head office:Osaka, Japan. President: Eiji Usui), a drugstore chain managing over 50 outlets, has opened Samurai Drugstore, an international online store for drugstore products fromJapan. The company...
2019-10-08 14:00
1359
Ascletis Appoints Former Novartis Global Head Dr. Handan He as Chief Scientific Officer
HANGZHOU, China and SHAOXING, China, Oct. 8, 2019 /PRNewswire/ -- Ascletis Pharma Inc. (1672.HK), an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral, cancer and fatty liver diseases, announces today that Dr.Han...
2019-10-08 08:00
2663
Innovent Biologics Announces a New Placement Raised HK$2,351.33 Million
SUZHOU, China, Oct. 4, 2019 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent" or "the Company") (HKEX: 01801), a world-class biopharmaceutical company that develops and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic and other major diseases, announc...
2019-10-04 16:11
3665
I-Mab Biopharma Receives IND Approval in China for Proprietary CD73 Antibody TJD5
SHANGHAI, Oct. 4, 2019 /PRNewswire/ -- I-Mab Biopharma ("I-Mab"), a China and U.S.-based clinical stage biopharmaceutical company exclusively focused on the discovery and development of novel or highly differentiated biologics in immuno-oncology and autoimmune diseases, today announced that its I...
2019-10-04 13:40
1443
Medicago's New Drug Submission accepted for scientific review by Health Canada: An important step for Medicago towards commercialization of its innovative influenza vaccine
QUEBEC CITY, Oct. 3, 2019 /PRNewswire/ -- Medicago, a biotechnology company and global leader in the development and production of plant-derived vaccines with headquarters inQuebec City, announces today that Health Canada accepted for scientific review its New Drug Submission (NDS) for a plant-ba...
2019-10-03 06:30
1505
Successful implementation of ClinSpark® at Phase I unit of a Top-10 Biopharmaceutical company
GRAFTON, Wisconsin, Oct. 2, 2019 /PRNewswire/ -- Following the successful implementation of ClinSpark® at the Phase I unit of a top-10 biopharmaceutical company inEurope, the first study database was locked where the entire trial was conducted within the system. FDA submission-ready eCRFs of all ...
2019-10-02 23:37
1084
Mayne Pharma Signs 20-Year Exclusive License and Supply Agreement for Novel Oral Contraceptive in the US
ADELAIDE, Australia, Oct. 2, 2019 * Mayne Pharma Group Limited (Mayne Pharma or Company) (ASX: MYX) has signed a 20‑year exclusive supply and license agreement with Mithra Pharmaceuticals, SA (Mithra) to commercialise a novel oral contraceptive comprising Estetrol (E4), and drospirenone, (E4/...
2019-10-02 12:01
8791
Clarivate Analytics introduces next-generation pre-clinical drug research platform with Cortellis Drug Discovery Intelligence
Updated solution enables enhanced analytics and greater utility of biology, chemistry and pharmacology data—within a single application LONDON and PHILADELPHIA, Oct. 2, 2019 /PRNewswire/ -- Clarivate Analytics plc (NYSE:CCC; CCC.WS), a global leader in providing trusted insights and analytics to...
2019-10-02 01:39
8266
CapsCanada Expands Growth to New State-of-the-Art Facility
DANIA BEACH, Florida, Oct. 1, 2019 /PRNewswire/ -- CapsCanada®, the leading innovator of vegetarian K-CAPS®, accelerates growth by relocating their headquarters to a new state-of-the-art facility strategically located in Dania Beach,Florida, with close proximity to two major interstate highways, ...
2019-10-01 19:00
1245
Shanghai Pharma Global Standard Stock Incentive Scheme to Push Innovation Refiled for Approval
SHANGHAI, Sept. 30, 2019 /PRNewswire/ -- Shanghai Pharmaceuticals Holding Co., Ltd. (Shanghai Pharma) (Hong Kong Stock Exchange: 2607) (Shanghai Stock Exchange: 601607) has launched a new stock incentive plan (the Plan) aligned with international standards aimed at retaining and attracting talent...
2019-10-01 04:00
8372
Yuyu Pharma Unveils New Corporate Logo
SEOUL, South Korea, Sept. 30, 2019 /PRNewswire/ -- Yuyu's corporate logo was
first created in 1941 to honor the company's proud history and highlight Yuyu's
image as a company on the cutting-edge of the industry.
2019-09-30 21:00
1592
ESMO 2019: CStone presents pooled safety data from the Phase 1b trial of CS1001, demonstrating promising overall safety and tolerability
SUZHOU, China, Sept. 30, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) released pooled safety data from the Phase Ib (GEMSTONE-101) study of the Company's anti-PD-L1 antibody CS1001 in a poster presentation at the European Society of Medical Oncology 2019 Con...
2019-09-30 18:29
2714
Ascletis Announces Departure of Chief Financial Officer
HANGZHOU and SHAOXING, China, Sept. 30, 2019 /PRNewswire/ -- Ascletis Pharma Inc. (1672.HK), an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral, cancer and fatty liver diseases, announces that Dr.Lindi Tan, Chi...
2019-09-30 16:30
1490
Ascletis Announces Departure of Chief Financial Officer
HANGZHOU and SHAOXING, China, Sept. 30, 2019 /PRNewswire/ -- Ascletis Pharma Inc. (1672.HK), an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral, cancer and fatty liver diseases, announces that Dr.Lindi Tan, Chi...
2019-09-30 16:30
2870
Interleukin 11 Identified as New Therapeutic Target for Idiopathic Pulmonary Fibrosis
* Idiopathic pulmonary fibrosis (IPF) is a severe and fatal disease that causes lung damage and scarring * Blocking a protein called interleukin-11 (IL11), which is abnormally high in the lungs of patients with IPF, can reverse lung fibrosis and scarring in preclinical studies * Enleofen Bi...
2019-09-30 15:00
1072
Adlai Nortye Presents Encouraging Phase 1b Study Data of AN0025 (an Oral EP4 Antagonist) for Locally Advanced Rectal Cancer at ESMO 2019
NORTH BRUNSWICK, New Jersey, Sept. 30, 2019 /PRNewswire/ -- Adlai Nortye Ltd. ("Adlai Nortye" or "the Company"), a global clinical-stage biopharmaceutical company dedicated to discovery, development and commercialization of new and effective drugs with a focus on Oncology, announced today at the ...
2019-09-30 13:41
1070
The 10th China (Taizhou) International Medical Expo successfully ended
NANJING, China, Sept. 30, 2019 /PRNewswire/ -- From September 18 to 20, the 10th
China (Taizhou) International Medical Expo was held in China Medical City
(CMS), according toChina (Taizhou) Medical Expo News Center.
2019-09-30 13:27
1214
Data From Ascensia Diabetes Care Shows High Accuracy of the CONTOUR®PLUS and CONTOUR®PLUS ONE BGMS in Low Blood Glucose Range and Potential Benefits From Using the CONTOUR®PLUS ONE BGMS With the Health2Sync App
HONG KONG, Sept. 30, 2019 /PRNewswire/ -- At the 21st Diabetes and Cardiovascular Risk Factors – East Meets West Symposium, Ascensia Diabetes Care has presented data from two studies, one analyzing the accuracy of blood glucose monitoring systems (BGMSs) in the low blood glucose range (LBGR) ...
2019-09-30 09:00
2566
Week's Top Stories
Most Reposted
Thailand Tops 2024 Consumer Review Awards by Agoda
[Picked up by 329 media titles]
2024-09-26 11:00
WARHAMMER 40,000: SPACE MARINE VR - DEFENDERS OF AVARAX NOW AVAILABLE AT ZERO LATENCY VR VENUES WORLDWIDE
[Picked up by 314 media titles]
2024-09-26 00:00
Advantech Unveils Expanded Singapore Office to Boost ASEAN Presence and Support AIoT Innovations with Strategic Partnerships
[Picked up by 312 media titles]
2024-09-23 13:37
Circles Partners with Telkomsel, Providing an Advanced Software-as-a-Service (SaaS) Platform to Enhance Customer Digital Experience
[Picked up by 297 media titles]
2024-09-27 10:00RuggON Debuts at the Largest Mining Expo, MINExpo 2024 Showcasing Rugged Solutions for the Trillion-Dollar Mining Market
[Picked up by 294 media titles]
2024-09-23 22:00
Most Read
RuggON Debuts at the Largest Mining Expo, MINExpo 2024 Showcasing Rugged Solutions for the Trillion-Dollar Mining Market
2024-09-23 22:00
6933
WARHAMMER 40,000: SPACE MARINE VR - DEFENDERS OF AVARAX NOW AVAILABLE AT ZERO LATENCY VR VENUES WORLDWIDE
2024-09-26 00:00
6853
Advantech Unveils Expanded Singapore Office to Boost ASEAN Presence and Support AIoT Innovations with Strategic Partnerships
2024-09-23 13:37
6316
Thailand Tops 2024 Consumer Review Awards by Agoda
2024-09-26 11:00
5639
Sobot Reflects on its Partnership with Lilith Games on Lilith's 11th Anniversary
2024-09-24 10:00
5543
